menu
    • menu
    [{"orgOrder":0,"company":"Gangnam Severance Hospital","sponsor":"Myung In Pharm | Yonsei University","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Triflusal","moa":"anti-inflammatory agents (salicylic acid derivatives)","graph1":"Neurology","graph2":"Phase IV","graph3":"Gangnam Severance Hospital","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Gangnam Severance Hospital \/ Myung In Pharm | Yonsei University","highestDevelopmentStatusID":"11","companyTruncated":"Gangnam Severance Hospital \/ Myung In Pharm | Yonsei University"}]

    Find Clinical Drug Pipeline Developments & Deals for Triflusal

    Menu

    Triflusal

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Gangnam Severance Hospital

                            Country arrow
                            AAPS
                            Not Confirmed

                            Gangnam Severance Hospital

                            Country arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Triflusal

                            Therapeutic Area : Neurology

                            Study Phase : Phase IV

                            Sponsor : Myung In Pharm | Yonsei University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping

                            Details : Triflusal is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cerebral Infarction.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 04, 2010

                            Lead Product(s) : Triflusal

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase IV

                            Sponsor : Myung In Pharm | Yonsei University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth